Insight

Treatment of CML in pregnant patients and patients who are breastfeeding

Photos of Jorge Cortes and

Jul 30, 2024, 13:23

Treatment of CML in pregnant patients and patients who are breastfeeding

FDA Oncology shared on X:

An expert panel convened by FDA provides perspectives on drug development for the treatment of chronic myeloid leukemia in pregnant patients and patients who are breastfeeding – via Clinical Cancer Research.

First author – Jorge Cortes and last author- Kelly Norsworthy.”

Read further.
Source: FDA Oncology/X

pregnant

Authors: Jorge E. Cortes, Elisabetta Abruzzese, Elyce H. Cardonick, Sonia Hernández-Díaz, Jamie Gutierrez, Mary S. Sardegna, Erica Torres-Chavez, Miriam Dinatale, Catherine C. Lerro, Brenda J. Gehrke, Stacy S. Shord, R. Angelo De Claro, Marc R. Theoret, Peter J. DeMaria, Kelly J. Norsworthy

Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding

AACR breastfeeding Brenda J. Gehrke cancer Catherine C. Lerro CCR Clinical Cancer Research CML Elisabetta Abruzzese Elyce H. Cardonick Erica Torres-Chavez FDA FDA Oncology Jamie Gutierrez Jorge Cortes Jorge E. Cortes Kelly J. Norsworthy Kelly Norsworthy Leukemia Marc R. Theoret Mary S. Sardegna Miriam Dinatale OncoDaily Oncology Peter J. DeMaria pregnant R. Angelo De Claro Sonia Hernández-Díaz Stacy S. Shord

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer